These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 12703962

  • 1. Low concentrations of arsenic induce vascular endothelial growth factor and nitric oxide release and stimulate angiogenesis in vitro.
    Kao YH, Yu CL, Chang LW, Yu HS.
    Chem Res Toxicol; 2003 Apr; 16(4):460-8. PubMed ID: 12703962
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells.
    Ma X, Ottino P, Bazan HE, Bazan NG.
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2915-21. PubMed ID: 15326102
    [Abstract] [Full Text] [Related]

  • 5. HB-EGF stimulates eNOS expression and nitric oxide production and promotes eNOS dependent angiogenesis.
    Mehta VB, Zhou Y, Radulescu A, Besner GE.
    Growth Factors; 2008 Dec; 26(6):301-15. PubMed ID: 18925469
    [Abstract] [Full Text] [Related]

  • 6. Caveolin-1 is important for nitric oxide-mediated angiogenesis in fibrin gels with human umbilical vein endothelial cells.
    Pan YM, Yao YZ, Zhu ZH, Sun XT, Qiu YD, Ding YT.
    Acta Pharmacol Sin; 2006 Dec; 27(12):1567-74. PubMed ID: 17112410
    [Abstract] [Full Text] [Related]

  • 7. Effect of norepinephrine on RhoA, MAP kinase, proliferation and VEGF expression in human umbilical vein endothelial cells.
    Seya Y, Fukuda T, Isobe K, Kawakami Y, Takekoshi K.
    Eur J Pharmacol; 2006 Dec 28; 553(1-3):54-60. PubMed ID: 17070516
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Endothelial cell response to lactate: implication of PAR modification of VEGF.
    Kumar VB, Viji RI, Kiran MS, Sudhakaran PR.
    J Cell Physiol; 2007 May 28; 211(2):477-85. PubMed ID: 17167776
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of endothelial cell differentiation and proinflammatory cytokine production during angiogenesis by allyl isothiocyanate and phenyl isothiocyanate.
    Thejass P, Kuttan G.
    Integr Cancer Ther; 2007 Dec 28; 6(4):389-99. PubMed ID: 18048887
    [Abstract] [Full Text] [Related]

  • 11. The effects of the inhibition of inducible nitric oxide synthase on angiogenesis of epithelial ovarian cancer.
    Malone JM, Saed GM, Diamond MP, Sokol RJ, Munkarah AR.
    Am J Obstet Gynecol; 2006 Apr 28; 194(4):1110-6; discussion 1116-8. PubMed ID: 16580304
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of vascular endothelial growth factor-induced angiogenesis by scopoletin through interrupting the autophosphorylation of VEGF receptor 2 and its downstream signaling pathways.
    Pan R, Dai Y, Gao XH, Lu D, Xia YF.
    Vascul Pharmacol; 2011 Apr 28; 54(1-2):18-28. PubMed ID: 21078410
    [Abstract] [Full Text] [Related]

  • 13. Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis.
    Lovren F, Pan Y, Shukla PC, Quan A, Teoh H, Szmitko PE, Peterson MD, Gupta M, Al-Omran M, Verma S.
    Am J Physiol Endocrinol Metab; 2009 Jun 28; 296(6):E1440-9. PubMed ID: 19351806
    [Abstract] [Full Text] [Related]

  • 14. Angiogenic effect of saponin extract from Panax notoginseng on HUVECs in vitro and zebrafish in vivo.
    Hong SJ, Wan JB, Zhang Y, Hu G, Lin HC, Seto SW, Kwan YW, Lin ZX, Wang YT, Lee SM.
    Phytother Res; 2009 May 28; 23(5):677-86. PubMed ID: 19107746
    [Abstract] [Full Text] [Related]

  • 15. Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in human malignant melanoma and their relation to angiogenesis.
    Tu YT, Tao J, Liu YQ, Li Y, Huang CZ, Zhang XB, Lin Y.
    Clin Exp Dermatol; 2006 May 28; 31(3):413-8. PubMed ID: 16681591
    [Abstract] [Full Text] [Related]

  • 16. Suppression of VEGF-mediated autocrine and paracrine interactions between prostate cancer cells and vascular endothelial cells by soy isoflavones.
    Guo Y, Wang S, Hoot DR, Clinton SK.
    J Nutr Biochem; 2007 Jun 28; 18(6):408-17. PubMed ID: 17142033
    [Abstract] [Full Text] [Related]

  • 17. Regulation of angiogenesis by Id-1 through hypoxia-inducible factor-1alpha-mediated vascular endothelial growth factor up-regulation in hepatocellular carcinoma.
    Lee TK, Poon RT, Yuen AP, Ling MT, Wang XH, Wong YC, Guan XY, Man K, Tang ZY, Fan ST.
    Clin Cancer Res; 2006 Dec 01; 12(23):6910-9. PubMed ID: 17145808
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of VEGF receptors significantly impairs mammary cancer growth in C3(1)/Tag transgenic mice through antiangiogenic and non-antiangiogenic mechanisms.
    Huh JI, Calvo A, Stafford J, Cheung M, Kumar R, Philp D, Kleinman HK, Green JE.
    Oncogene; 2005 Jan 27; 24(5):790-800. PubMed ID: 15592523
    [Abstract] [Full Text] [Related]

  • 19. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
    Timke C, Zieher H, Roth A, Hauser K, Lipson KE, Weber KJ, Debus J, Abdollahi A, Huber PE.
    Clin Cancer Res; 2008 Apr 01; 14(7):2210-9. PubMed ID: 18381963
    [Abstract] [Full Text] [Related]

  • 20. Paradoxical effects of ethoxidine, a topoisomerase I inhibitor, in the cellular processes leading to angiogenesis on endothelial cells.
    Clere N, Faure S, Helesbeux JJ, Duval O, Andriantsitohaina R.
    Carcinogenesis; 2011 Mar 01; 32(3):286-95. PubMed ID: 21135154
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.